Drug Trial Radar · NCT03336619
A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated Influenza
Last checked: Nov 20, 2026Latest source record: Jun 28, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,030
Actual
Start
Jan 17, 2018
Primary completion
Apr 17, 2019
Study completion Apr 17, 2019
Sponsor
- Lead sponsor
- Romark Laboratories L.C.Industry
- Sponsor type
- Industry
- First posted
- Nov 8, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Trial to evaluate efficacy and safety of nitazoxanide (NTZ) in the treatment of uncomplicated influenza.
Conditions
- Influenza
Interventions
NitazoxanideDrug
Nitazoxanide 600 mg administered orally twice daily for five days
PlaceboDrug
Placebo administered orally twice daily for five days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time From First Dose to Symptom ResponseTime frame: Up to 21 days
Locations
38 sites in 3 countries. Site status is shown where the registry gives one.
Vanguard Study Site
Alabaster, Alabama
Vanguard Study Site
Birmingham, Alabama
Vanguard Study Site
Birmingham, Alabama
Vanguard Study Site
Hoover, Alabama
Vanguard Study Site
Pelham, Alabama
Vanguard Study Site
Goodyear, Arizona
Vanguard Study Site
Tolleson, Arizona
Vanguard Study Site
Hot Springs, Arkansas
Vanguard Study Site
Anaheim, California
Vanguard Study Site
Westminster, California
Vanguard Study Site
Lauderdale Lakes, Florida
Vanguard Study Site
Orlando, Florida
Vanguard Study Site
Valparaiso, Indiana
Vanguard Study Site
New Orleans, Louisiana
Vanguard Study Site
St Louis, Missouri
Vanguard Study Site
Missoula, Montana
Vanguard Study Site
Brooklyn, New York
Vanguard Study Site
Cincinnati, Ohio
Vanguard Study Site
Columbus, Ohio
Vanguard Study Site
Dayton, Ohio
Vanguard Study Site
Medford, Oregon
Vanguard Study Site
Rapid City, South Dakota
Vanguard Study Site
Jackson, Tennessee
Vanguard Study Site
Smyrna, Tennessee
Vanguard Study Site
Austin, Texas
Vanguard Study Site
Carrollton, Texas
Vanguard Study Site
Dallas, Texas
Vanguard Study Site
Dallas, Texas
Vanguard Study Site
Fort Worth, Texas
Vanguard Study Site
Houston, Texas
Vanguard Study Site
Pharr, Texas
Vanguard Study Site
Plano, Texas
Vanguard Study Site
Plano, Texas
Vanguard Study Site
St. George, Utah
Vanguard Study Site
Morayfield, Queensland, Australia
Vanguard Study Site
Sherwood, Queensland, Australia
Vanguard Study Site
Victoria Point, Queensland, Australia
Vanguard Study Site
Ponce, Puerto Rico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.